Virology-the path forward
In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.
| Errataetall: |
ErratumIn: J Virol. 2024 Mar 19;98(3):e0007424. - PMID 38334328 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:98 |
|---|---|
| Enthalten in: |
Journal of virology - 98(2024), 1 vom: 23. Jan., Seite e0179123 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Biosafety |
|---|
| Anmerkungen: |
Date Completed 30.01.2024 Date Revised 19.03.2024 published: Print-Electronic ErratumIn: J Virol. 2024 Mar 19;98(3):e0007424. - PMID 38334328 Citation Status MEDLINE |
|---|
| doi: |
10.1128/jvi.01791-23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366592998 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366592998 | ||
| 003 | DE-627 | ||
| 005 | 20240319232430.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/jvi.01791-23 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1336.xml |
| 035 | |a (DE-627)NLM366592998 | ||
| 035 | |a (NLM)38168672 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rasmussen, Angela L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Virology-the path forward |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.01.2024 | ||
| 500 | |a Date Revised 19.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: J Virol. 2024 Mar 19;98(3):e0007424. - PMID 38334328 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a biosafety | |
| 650 | 4 | |a emergence | |
| 650 | 4 | |a oversight | |
| 650 | 4 | |a virology | |
| 700 | 1 | |a Gronvall, Gigi K |e verfasserin |4 aut | |
| 700 | 1 | |a Lowen, Anice C |e verfasserin |4 aut | |
| 700 | 1 | |a Goodrum, Felicia |e verfasserin |4 aut | |
| 700 | 1 | |a Alwine, James |e verfasserin |4 aut | |
| 700 | 1 | |a Andersen, Kristian G |e verfasserin |4 aut | |
| 700 | 1 | |a Anthony, Simon J |e verfasserin |4 aut | |
| 700 | 1 | |a Baines, Joel |e verfasserin |4 aut | |
| 700 | 1 | |a Banerjee, Arinjay |e verfasserin |4 aut | |
| 700 | 1 | |a Broadbent, Andrew J |e verfasserin |4 aut | |
| 700 | 1 | |a Brooke, Christopher B |e verfasserin |4 aut | |
| 700 | 1 | |a Campos, Samuel K |e verfasserin |4 aut | |
| 700 | 1 | |a Caposio, Patrizia |e verfasserin |4 aut | |
| 700 | 1 | |a Casadevall, Arturo |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Gary C |e verfasserin |4 aut | |
| 700 | 1 | |a Cliffe, Anna R |e verfasserin |4 aut | |
| 700 | 1 | |a Collins-McMillen, Donna |e verfasserin |4 aut | |
| 700 | 1 | |a Connell, Nancy |e verfasserin |4 aut | |
| 700 | 1 | |a Damania, Blossom |e verfasserin |4 aut | |
| 700 | 1 | |a Daugherty, Matthew D |e verfasserin |4 aut | |
| 700 | 1 | |a Debbink, Kari |e verfasserin |4 aut | |
| 700 | 1 | |a Dermody, Terence S |e verfasserin |4 aut | |
| 700 | 1 | |a DiMaio, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Duprex, W Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Emerman, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Galloway, Denise A |e verfasserin |4 aut | |
| 700 | 1 | |a Garry, Robert F |e verfasserin |4 aut | |
| 700 | 1 | |a Goldstein, Stephen A |e verfasserin |4 aut | |
| 700 | 1 | |a Greninger, Alexander L |e verfasserin |4 aut | |
| 700 | 1 | |a Hartman, Amy L |e verfasserin |4 aut | |
| 700 | 1 | |a Hogue, Brenda G |e verfasserin |4 aut | |
| 700 | 1 | |a Horner, Stacy M |e verfasserin |4 aut | |
| 700 | 1 | |a Hotez, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Jung, Jae U |e verfasserin |4 aut | |
| 700 | 1 | |a Kamil, Jeremy P |e verfasserin |4 aut | |
| 700 | 1 | |a Karst, Stephanie M |e verfasserin |4 aut | |
| 700 | 1 | |a Laimins, Lou |e verfasserin |4 aut | |
| 700 | 1 | |a Lakdawala, Seema S |e verfasserin |4 aut | |
| 700 | 1 | |a Landais, Igor |e verfasserin |4 aut | |
| 700 | 1 | |a Letko, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Lindenbach, Brett |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Shan-Lu |e verfasserin |4 aut | |
| 700 | 1 | |a Luftig, Micah |e verfasserin |4 aut | |
| 700 | 1 | |a McFadden, Grant |e verfasserin |4 aut | |
| 700 | 1 | |a Mehle, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Morrison, Juliet |e verfasserin |4 aut | |
| 700 | 1 | |a Moscona, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Mühlberger, Elke |e verfasserin |4 aut | |
| 700 | 1 | |a Munger, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Münger, Karl |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Eain |e verfasserin |4 aut | |
| 700 | 1 | |a Neufeldt, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Nikolich, Janko Z |e verfasserin |4 aut | |
| 700 | 1 | |a O'Connor, Christine M |e verfasserin |4 aut | |
| 700 | 1 | |a Pekosz, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Permar, Sallie R |e verfasserin |4 aut | |
| 700 | 1 | |a Pfeiffer, Julie K |e verfasserin |4 aut | |
| 700 | 1 | |a Popescu, Saskia V |e verfasserin |4 aut | |
| 700 | 1 | |a Purdy, John G |e verfasserin |4 aut | |
| 700 | 1 | |a Racaniello, Vincent R |e verfasserin |4 aut | |
| 700 | 1 | |a Rice, Charles M |e verfasserin |4 aut | |
| 700 | 1 | |a Runstadler, Jonathan A |e verfasserin |4 aut | |
| 700 | 1 | |a Sapp, Martin J |e verfasserin |4 aut | |
| 700 | 1 | |a Scott, Rona S |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Gregory A |e verfasserin |4 aut | |
| 700 | 1 | |a Sorrell, Erin M |e verfasserin |4 aut | |
| 700 | 1 | |a Speranza, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Streblow, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Tibbetts, Scott A |e verfasserin |4 aut | |
| 700 | 1 | |a Toth, Zsolt |e verfasserin |4 aut | |
| 700 | 1 | |a Van Doorslaer, Koenraad |e verfasserin |4 aut | |
| 700 | 1 | |a Weiss, Susan R |e verfasserin |4 aut | |
| 700 | 1 | |a White, Elizabeth A |e verfasserin |4 aut | |
| 700 | 1 | |a White, Timothy M |e verfasserin |4 aut | |
| 700 | 1 | |a Wobus, Christiane E |e verfasserin |4 aut | |
| 700 | 1 | |a Worobey, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Yamaoka, Satoko |e verfasserin |4 aut | |
| 700 | 1 | |a Yurochko, Andrew |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of virology |d 1967 |g 98(2024), 1 vom: 23. Jan., Seite e0179123 |w (DE-627)NLM000006866 |x 1098-5514 |7 nnns |
| 773 | 1 | 8 | |g volume:98 |g year:2024 |g number:1 |g day:23 |g month:01 |g pages:e0179123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1128/jvi.01791-23 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 98 |j 2024 |e 1 |b 23 |c 01 |h e0179123 | ||